ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener πŸ¦‹ Butterfly 8 Analysts πŸ›οΈ Policy 🎬 Video β˜… Watchlist 🎲 Prediction Markets πŸ“Š RQD Track Record πŸ“… Next Catalysts πŸ›‘οΈ Overlap & Crash X-Ray πŸ“° Live Wire πŸ‹ 13F Whales πŸ›οΈ Congress & CEO Buys πŸ† $100K Arena ⌘ Pro Terminal πŸ“ Methodology & Corrections
Stock Ratings / Consumer Discretionary / AHG / insiders
RSKD (54) QNST (70) MAX (69) NUTX (84) ⌘ Pro Terminal β†’

Akso Health Group ADS (AHG) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$1.31 +4.17% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.32

Akso Health Group ADS (AHG) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

πŸ“Š Historical Track Record Warning: Scores below 50 (32/100 Β· E) historically underperformed SPY in 71% of rolling 90-day windows β†’
ROARABLE E β€’ RED ALERT Cap $1.08B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on AHG Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is AHG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Akso Health Group ADS (NASDAQ: AHG) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.31 (+4.17% 1D, market cap $1.08B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, AHG ranks #845 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does AHG compare to RSKD and QNST in the Consumer Discretionary sector?
β–Ό

Within the Consumer Discretionary sector (Business Services), AHG carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of -0.1%, and ROIC of β€”. By comparison, RSKD (Riskified Ltd. (Class A)) holds a D+ grade (54/100 RQD, P/E N/A, ROIC -20.3%, cap $1.17B) and QNST (QuinStreet Inc.) posts a B- grade (70/100 RQD, P/E N/A, ROIC 2.6%, cap $995.7M). Among the 5-stock peer group, NUTX leads on earnings multiple (20.3x) while NUTX leads on capital efficiency (85.0% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for AHG?
β–Ό

Per AHG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001702318), Akso Health Group ADS generated $13.8M in revenue (-6.4% YoY), -$18.7M in net income, and -$12.8M in free cash flow against $212.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.32 (+0.56%)🧬 Dilution Drag (+2.48% YoY Shares)βš™οΈ Cash Engine: 8/20 (D-) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (32/100 Β· E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERRED ALERT β€’ E
025507510032
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E Β· Rk E
Cash (8)Whales (8)SEC (8)Macro (5)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-11.5% Base Target
$3 Bull$1 Base$1 Bear
πŸ“¬ FREE AHG RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for AHG)Realized 20D OHLCV Swing Band: Β±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
πŸ” WHY AHG SCORES 32/100 (E) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Cash Engine Quality+8/20 pts (25% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 0% Gross Margin

β–² #2 Bullish Driver: Whale & Options Positioning+8/20 pts (25% of score)

20D Institutional Volume Accumulation (Β±12.5% realized swing band)

β–Ό #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
40
Grade D$1.36-9.6% Next Q
Q2 (-2Q)
37
Grade E$1.23+14.6% Next Q
Q3 (-1Q)
35
Grade E$1.41-7.1% Next Q
Current
32
Grade E$1.31-9.2% Hist 90D Ξ±
Trajectory: D (40) β†’ E (32)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a AHG Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While AHG currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.03) and Max Pain ($1.38) forces dealer call-delta covering toward $2.63.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $AHGβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œAHG Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
YES 32%NO 68%Trade / Inspect Odds β†’
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

AHG Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (AHG)

No recent open-market Form 4 cluster sales or emergency dumps flagged on AHG. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring AHG)

  • βœ“Walkthrough of AHG's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) β†’$100K Arena
AHG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -38.79%β–Ό DESCENDING CHANNEL
2026-11-03O $1.33H $1.33L $1.26C $1.31VOL 4.9K
RES: $1.49SUP: $0.49SMA50: $1.03SMA200: $1.51
$2.31$1.87$1.42$0.98$0.54RES $1.49SUP $0.49$1.312026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

AHG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

πŸ¦‹ AHG Butterfly Map β†’ + Track AHG β†’
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. -6.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on AHG today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for AHG. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for AHG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (AHG)

Consumer Discretionary Rank #845 of 1011 βš”οΈ RSKD vs AHG Full Matrix β†’

1. Head-to-Head Consumer Discretionary Peer Comparison (AHG vs. RSKD, QNST, MAX, NUTX)

Industry: Business Services (90 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Akso Health Group ADS (AHG) ranks #845 by composite RQD confidence (32/100, grade E) and #500 by equity capitalization ($1.08B). Within this direct 5-issuer industry benchmark cohort, NUTX leads on earnings valuation at 20.3x trailing P/E, while NUTX leads on capital efficiency and profitability with 85.0% ROIC and 50.8% gross margin. NUTX currently holds the highest overall quantitative score in the immediate peer group at 84/100 (A-) compared with AHG at 32/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
AHG ACTIVE
Akso Health Group ADS
E 32/100 β€” -0.1% β€” +4.17% $1.08B Benchmark Subject
RSKD
Riskified Ltd. (Class A)
D+ 54/100 β€” 51.7% -20.3% -1.05% $1.17B /rskd-vs-ahg β†’
QNST
QuinStreet Inc.
B- 70/100 β€” 10.1% 2.6% +0.92% $995.7M /qnst-vs-ahg β†’
MAX
MediaAlpha Inc. (Class A)
C+ 69/100 32.6x 15.0% 19.7% +0.20% $873.1M /max-vs-ahg β†’
NUTX
Nutex Health Inc.
A- 84/100 20.3x 50.8% 85.0% -7.27% $1.37B /nutx-vs-ahg β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2026-03-31 β€’ CIK 0001702318

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Akso Health Group ADS (AHG) reported GAAP revenue of $13.8M (-6.4% vs. FY2024 revenue of $14.8M , and +472.9% cumulative change since FY2023) , GAAP net income of -$18.7M, operating cash flow of -$12.8M, and free cash flow of -$12.8M (-1350.9% YoY). On the balance sheet, AHG closed FY2025 with $212.0M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2026-03-31 $13.8M -$18.7M -$12.8M -$12.8M $212.0M β€”
FY2024 (FY) 2025-03-31 $14.8M -$135.0M $1.2M $1.0M β€” β€”
FY2023 (FY) 2024-03-31 $2.4M -$9.5M $1.4M $1.4M β€” β€”

3. AHG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is AHG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Akso Health Group ADS (NASDAQ: AHG) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.31 (+4.17% 1D, market cap $1.08B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, AHG ranks #845 in composite RQD confidence.

How does AHG compare to RSKD and QNST in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Business Services), AHG carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of -0.1%, and ROIC of β€”. By comparison, RSKD (Riskified Ltd. (Class A)) holds a D+ grade (54/100 RQD, P/E N/A, ROIC -20.3%, cap $1.17B) and QNST (QuinStreet Inc.) posts a B- grade (70/100 RQD, P/E N/A, ROIC 2.6%, cap $995.7M). Among the 5-stock peer group, NUTX leads on earnings multiple (20.3x) while NUTX leads on capital efficiency (85.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for AHG?

Per AHG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001702318), Akso Health Group ADS generated $13.8M in revenue (-6.4% YoY), -$18.7M in net income, and -$12.8M in free cash flow against $212.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is AHG trading relative to its 50-day, 200-day, and 52-week technical levels?

AHG last traded at $1.31 (+4.17% on volume of 2,951 shares), positioning the stock +27.18% above its 50-day simple moving average ($1.03) and -13.25% below its 200-day simple moving average ($1.51). Across its 52-week range of $0.68 to $2.50, AHG sits at the 34.6% percentile with a 14-day RSI of 52.9 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($1.15 to $1.47).

Direct Sub-Reports: AHG RQD Cockpit AHG 12M Forecast AHG Earnings & Move AHG Dividends & DRIP AHG Insiders & 13F AHG Whale Options AHG Profit Sankey AHG News & Why
ROARABLE RATING BRIEF β€’ RQD 32/100 (E) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

AHG β€” Akso Health Group ADS: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:30:34Z

1. Roarable Rating Brief: What This Means to a Prospective Investor

AHG holds a score of 34 out of 100, a letter grade of E, and the verdict label "Roarable Strong Sell β€” Forensic Risk / Avoid." Across the five pillars, the fundamental cash engine scores 8 out of 20, with ROIC at 0% and an FCF yield of -1.12%, indicating the business is not currently converting capital into returns or positive free cash flow. The whale 13F flow pillar scores 10 out of 20, reflecting institutional accumulation and options positioning that is weaker than the top of the scale. Insider conviction scores 3 out of 20, the lowest pillar, drawn from the SEC Form 4 and Congressional PTR cluster flow. Macro regime fit scores 5 out of 20 with a beta of 1.0 and sector sensitivity noted. Forensic balance sheet scores 8 out of 20, citing an Altman Z of 2.5, a Piotroski F of 2 out of 9, and a Debt/Equity of 0.5. For a prospective investor, the upside case rests on any reversal in cash generation, which the rating does not currently show, while the valuation tradeoff is that a low share price alone does not offset negative returns on capital. The cumulative pillar profile signals elevated forensic risk and weak insider conviction rather than a constructive setup.

2. Business Model, Unit Margins & SEC Financial Trajectory

Akso Health Group ADS is a NASDAQ-listed issuer classified in the Consumer Discretionary sector and Business Services industry,. β€” for specific product lines, customer segments, or revenue model details. The profile identifies the company only at the sector, industry, and exchange level.

Operating margin is -60% and net margin is -60%, with gross margin at -0.1% in the market data. ROIC is 0%. The Altman Z-Score is 2.5 and the Piotroski F-Score is 2 out of 9, . Debt/Equity is 0.5 per the same source.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case: The share price of 1.33 sits near the low end of its $0.68 - $2.5 52-week range while the company reports 2.5 Altman Z-Score. With Fundamental Cash Engine at 8/20 (ROIC β€”, FCF yield -1.12%) and Institutional Whale Flow at 8/20, sustained execution supports upside toward the top of the $0.68 – $2.50 52-week range.
  • 🐻 Primary Bear Case: Negative operating margin of -60% and ROIC of 0% alongside a Piotroski F-Score of 2 out of 9 signal weak cash generation and elevated forensic risk. Investors must weigh current valuation against -60.0% operating margins and a 1.00 macro beta if sector demand softens.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Business Services (Consumer Discretionary), AHG carries a macro regime beta of 1.00 and gross margin of -0.1%.

  • Key Question #1: What drove the FY 2024 operating loss of -$166.3M against revenue of $14.8M, and does the FY 2025 figure reflect a structural change?
  • Key Question #2: What is the EPS for any period, given that EPS is listed as N/A across all three filings?
  • Key Question #3: What supply-chain or sector links exist, given the butterfly graph reports no supply chain and no links?

AHG Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Akso Health Group ADS (AHG) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to AHG Debate Forum (3) ↓
🟑 MARKET WIRE TradingView β€’ 10d ago
Akso Health Group Estimates – NASDAQ:AHG

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9LTXc1MURydmdGcFBPc0xqZ3N2MFJLaXd0Zy1IS1VfdU4tMXV2RU50aDJwS3AwQkhLUTF6ZUdoUXFvbDhOQ0oxYVRyc3BrYXFyWnE3YjZkVU0zbG1EVXdrX2NudDdVN2VwYmQ0YkNOcmpNem04cnFB?oc=5"

Read Full Source β†—
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

AHG Bull vs. Bear Conversation Board β€” What's Your Call at $1.31?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON AHG 🐻 33% BEARISH CONVICTION
1. Pick Your Side on AHG:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
SI SiliconVal_Bull Growth & Tech Investor πŸ‚ BULLISH 🎯 Target: $1.45 (+15.1%)
πŸ“Œ Pinned Debate

The share price of 1.33 sits near the low end of its $0.68 - $2.5 52-week range while the company reports 2.5 Altman Z-Score.

The share price of 1.33 sits near the low end of its $0.68 - $2.5 52-week range while the company reports 2.5 Altman Z-Score.. When you look under the hood at AHG, Fundamental Cash Engine is 8/20 with -0.1% gross margins and 0.0% ROIC. Bears are staring in the rearview mirror while institutional 13F flow (8/20) has been quietly accumulating below $2.50. My 12M target is $1.45.

VolSurface_Trader πŸ‚ BULL

@CreditSpread_Watch Shorting a 8/20 institutional whale-flow stock at $1.26 is dangerous when funds are rotating into Consumer Discretionary.

CR CreditSpread_Watch Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $1.01 (-19.8%)
Spot @ $1.26

Negative operating margin of -60% and ROIC of 0% alongside a Piotroski F-Score of 2 out of 9 signal weak cash generation and elevated f

Negative operating margin of -60% and ROIC of 0% alongside a Piotroski F-Score of 2 out of 9 signal weak cash generation and elevated forensic risk.. Look at the math on AHG: paying current EV/EBITDA multiples for 0.0% ROIC and -60.0% operating margins leaves zero margin of safety if Business Services demand softens. I'd wait for a retest of $1.11 before getting long.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%